 | • レポートコード：QYR9ST04477 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、ホジキンリンパ腫治療の世界市場について調査・分析し、ホジキンリンパ腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（アルキル化抗腫瘍剤、抗生物質抗腫瘍剤、抗腫瘍薬ビンカアルカロイド剤、ポドフィロトキシン誘導体抗腫瘍剤、抗代謝物抗腫瘍剤、アントラサイクリン抗腫瘍剤、抗微小管抗腫瘍剤、副腎皮質ステロイド）、用途別（病院、学術研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のホジキンリンパ腫治療市場動向 ・主要企業別マーケットシェア ・ホジキンリンパ腫治療の種類別市場規模2014-2019 （アルキル化抗腫瘍剤、抗生物質抗腫瘍剤、抗腫瘍薬ビンカアルカロイド剤、ポドフィロトキシン誘導体抗腫瘍剤、抗代謝物抗腫瘍剤、アントラサイクリン抗腫瘍剤、抗微小管抗腫瘍剤、副腎皮質ステロイド） ・ホジキンリンパ腫治療の用途別市場規模2014-2019 （病院、学術研究機関） ・ホジキンリンパ腫治療の北米市場：主要企業・種類別/用途別市場規模 ・ホジキンリンパ腫治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・ホジキンリンパ腫治療の中国市場：主要企業・種類別/用途別市場規模 ・ホジキンリンパ腫治療の日本国内市場：主要企業・種類別/用途別市場規模 ・ホジキンリンパ腫治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・ホジキンリンパ腫治療のインド市場：主要企業・種類別/用途別市場規模 ・ホジキンリンパ腫治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol Myers Squibb、F. Hoffmann-La Roche、Merck、Pfizer） ・ホジキンリンパ腫治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Hodgkin’s Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the lymphatic system grow unusually and may spread beyond the lymphatic system. The infection-fighting properties of the lymphocytes are lost, making the person more susceptible to infection. The main treatments used are chemotherapy, followed by radiotherapy or chemotherapy alone. Generally surgery is not used as a treatment for the condition.The Hodgkin’s lymphoma therapeutics pipeline is expected to witness considerable growth in the coming years as the researchers are making novel drug delivery system for the treatment for cancer. The government agencies such as National Cancer Institute and American Cancer Society are supporting the growth of the Hodgkin’s lymphoma (HL) therapeutics pipeline by providing funding, designations and grants for speeding up the drug development process. High prevalence of cancer, increasing awareness regarding cancer treatment, technological advancements and high demand for safe and effective medication are driving the growth of the Hodgkin’s Lymphoma therapeutics pipeline.
In 2018, the global Hodgkin’s Lymphoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hodgkin’s Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hodgkin’s Lymphoma Therapeutics development in United States, Europe and China.
The key players covered in this study
Bristol Myers Squibb
F. Hoffmann-La Roche
Merck
Pfizer
…
Market segment by Type, the product can be split into
Alkylating Antineoplastic Agents
Antibiotic Antineoplastic Agents
Antineoplastics Vinca Alkaloid Agents
Podophyllotoxin Derivative Antineoplastic Agents
Antimetabolite Antineoplastic Agents
Anthracycline Antineoplastic Agents
Antimicrotubular Antineoplastics
Corticosteroids
Market segment by Application, split into
Hospitals
Academic and Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hodgkin’s Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Hodgkin’s Lymphoma Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hodgkin’s Lymphoma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hodgkin’s Lymphoma Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Alkylating Antineoplastic Agents
1.4.3 Antibiotic Antineoplastic Agents
1.4.4 Antineoplastics Vinca Alkaloid Agents
1.4.5 Podophyllotoxin Derivative Antineoplastic Agents
1.4.6 Antimetabolite Antineoplastic Agents
1.4.7 Anthracycline Antineoplastic Agents
1.4.8 Antimicrotubular Antineoplastics
1.4.9 Corticosteroids
1.5 Market by Application
1.5.1 Global Hodgkin’s Lymphoma Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Academic and Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hodgkin’s Lymphoma Therapeutics Market Size
2.2 Hodgkin’s Lymphoma Therapeutics Growth Trends by Regions
2.2.1 Hodgkin’s Lymphoma Therapeutics Market Size by Regions (2014-2025)
2.2.2 Hodgkin’s Lymphoma Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hodgkin’s Lymphoma Therapeutics Market Size by Manufacturers
3.1.1 Global Hodgkin’s Lymphoma Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Hodgkin’s Lymphoma Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hodgkin’s Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Hodgkin’s Lymphoma Therapeutics Key Players Head office and Area Served
3.3 Key Players Hodgkin’s Lymphoma Therapeutics Product/Solution/Service
3.4 Date of Enter into Hodgkin’s Lymphoma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hodgkin’s Lymphoma Therapeutics Market Size by Type (2014-2019)
4.2 Global Hodgkin’s Lymphoma Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Hodgkin’s Lymphoma Therapeutics Market Size (2014-2019)
5.2 Hodgkin’s Lymphoma Therapeutics Key Players in United States
5.3 United States Hodgkin’s Lymphoma Therapeutics Market Size by Type
5.4 United States Hodgkin’s Lymphoma Therapeutics Market Size by Application
6 Europe
6.1 Europe Hodgkin’s Lymphoma Therapeutics Market Size (2014-2019)
6.2 Hodgkin’s Lymphoma Therapeutics Key Players in Europe
6.3 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Type
6.4 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Application
7 China
7.1 China Hodgkin’s Lymphoma Therapeutics Market Size (2014-2019)
7.2 Hodgkin’s Lymphoma Therapeutics Key Players in China
7.3 China Hodgkin’s Lymphoma Therapeutics Market Size by Type
7.4 China Hodgkin’s Lymphoma Therapeutics Market Size by Application
8 Japan
8.1 Japan Hodgkin’s Lymphoma Therapeutics Market Size (2014-2019)
8.2 Hodgkin’s Lymphoma Therapeutics Key Players in Japan
8.3 Japan Hodgkin’s Lymphoma Therapeutics Market Size by Type
8.4 Japan Hodgkin’s Lymphoma Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hodgkin’s Lymphoma Therapeutics Market Size (2014-2019)
9.2 Hodgkin’s Lymphoma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Hodgkin’s Lymphoma Therapeutics Market Size by Type
9.4 Southeast Asia Hodgkin’s Lymphoma Therapeutics Market Size by Application
10 India
10.1 India Hodgkin’s Lymphoma Therapeutics Market Size (2014-2019)
10.2 Hodgkin’s Lymphoma Therapeutics Key Players in India
10.3 India Hodgkin’s Lymphoma Therapeutics Market Size by Type
10.4 India Hodgkin’s Lymphoma Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Hodgkin’s Lymphoma Therapeutics Market Size (2014-2019)
11.2 Hodgkin’s Lymphoma Therapeutics Key Players in Central & South America
11.3 Central & South America Hodgkin’s Lymphoma Therapeutics Market Size by Type
11.4 Central & South America Hodgkin’s Lymphoma Therapeutics Market Size by Application
12 International Players Profiles
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hodgkin’s Lymphoma Therapeutics Introduction
12.1.4 Bristol Myers Squibb Revenue in Hodgkin’s Lymphoma Therapeutics Business (2014-2019)
12.1.5 Bristol Myers Squibb Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hodgkin’s Lymphoma Therapeutics Introduction
12.2.4 F. Hoffmann-La Roche Revenue in Hodgkin’s Lymphoma Therapeutics Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hodgkin’s Lymphoma Therapeutics Introduction
12.3.4 Merck Revenue in Hodgkin’s Lymphoma Therapeutics Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hodgkin’s Lymphoma Therapeutics Introduction
12.4.4 Pfizer Revenue in Hodgkin’s Lymphoma Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hodgkin's Lymphoma Therapeutics Key Market Segments
Table Key Players Hodgkin's Lymphoma Therapeutics Covered
Table Global Hodgkin's Lymphoma Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hodgkin's Lymphoma Therapeutics Market Size Market Share by Type 2014-2025
Figure Alkylating Antineoplastic Agents Figures
Table Key Players of Alkylating Antineoplastic Agents
Figure Antibiotic Antineoplastic Agents Figures
Table Key Players of Antibiotic Antineoplastic Agents
Figure Antineoplastics Vinca Alkaloid Agents Figures
Table Key Players of Antineoplastics Vinca Alkaloid Agents
Figure Podophyllotoxin Derivative Antineoplastic Agents Figures
Table Key Players of Podophyllotoxin Derivative Antineoplastic Agents
Figure Antimetabolite Antineoplastic Agents Figures
Table Key Players of Antimetabolite Antineoplastic Agents
Figure Anthracycline Antineoplastic Agents Figures
Table Key Players of Anthracycline Antineoplastic Agents
Figure Antimicrotubular Antineoplastics Figures
Table Key Players of Antimicrotubular Antineoplastics
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Table Global Hodgkin's Lymphoma Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Academic and Research Institutes Case Studies
Figure Hodgkin's Lymphoma Therapeutics Report Years Considered
Table Global Hodgkin's Lymphoma Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Hodgkin's Lymphoma Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hodgkin's Lymphoma Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Hodgkin's Lymphoma Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Hodgkin's Lymphoma Therapeutics Market Share by Regions 2014-2019
Figure Global Hodgkin's Lymphoma Therapeutics Market Share by Regions 2014-2019
Figure Global Hodgkin's Lymphoma Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Hodgkin's Lymphoma Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hodgkin's Lymphoma Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Hodgkin's Lymphoma Therapeutics Market Share by Manufacturers in 2018
Table Global Hodgkin's Lymphoma Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hodgkin's Lymphoma Therapeutics Product/Solution/Service
Table Date of Enter into Hodgkin's Lymphoma Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hodgkin's Lymphoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Hodgkin's Lymphoma Therapeutics Market Size Share by Type (2014-2019)
Figure Global Hodgkin's Lymphoma Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Hodgkin's Lymphoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Hodgkin's Lymphoma Therapeutics Market Size Share by Application (2014-2019)
Figure Global Hodgkin's Lymphoma Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Hodgkin's Lymphoma Therapeutics Revenue Market Share by Application in 2018
Figure United States Hodgkin's Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Hodgkin's Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Hodgkin's Lymphoma Therapeutics Market Share (2018-2019)
Table United States Hodgkin's Lymphoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Hodgkin's Lymphoma Therapeutics Market Share by Type (2014-2019)
Table United States Hodgkin's Lymphoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Hodgkin's Lymphoma Therapeutics Market Share by Application (2014-2019)
Figure Europe Hodgkin's Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Hodgkin's Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Hodgkin's Lymphoma Therapeutics Market Share (2018-2019)
Table Europe Hodgkin's Lymphoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Hodgkin's Lymphoma Therapeutics Market Share by Type (2014-2019)
Table Europe Hodgkin's Lymphoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Hodgkin's Lymphoma Therapeutics Market Share by Application (2014-2019)
Figure China Hodgkin's Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Hodgkin's Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Hodgkin's Lymphoma Therapeutics Market Share (2018-2019)
Table China Hodgkin's Lymphoma Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Hodgkin's Lymphoma Therapeutics Market Share by Type (2014-2019)
Table China Hodgkin's Lymphoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Hodgkin's Lymphoma Therapeutics Market Share by Application (2014-2019)
Figure Japan Hodgkin's Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Hodgkin's Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Hodgkin's Lymphoma Therapeutics Market Share (2018-2019)
Table Japan Hodgkin's Lymphoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Hodgkin's Lymphoma Therapeutics Market Share by Type (2014-2019)
Table Japan Hodgkin's Lymphoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Hodgkin's Lymphoma Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Hodgkin's Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hodgkin's Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hodgkin's Lymphoma Therapeutics Market Share (2018-2019)
Table Southeast Asia Hodgkin's Lymphoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hodgkin's Lymphoma Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Hodgkin's Lymphoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hodgkin's Lymphoma Therapeutics Market Share by Application (2014-2019)
Figure India Hodgkin's Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Hodgkin's Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Hodgkin's Lymphoma Therapeutics Market Share (2018-2019)
Table India Hodgkin's Lymphoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Hodgkin's Lymphoma Therapeutics Market Share by Type (2014-2019)
Table India Hodgkin's Lymphoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Hodgkin's Lymphoma Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Hodgkin's Lymphoma Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hodgkin's Lymphoma Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hodgkin's Lymphoma Therapeutics Market Share (2018-2019)
Table Central & South America Hodgkin's Lymphoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hodgkin's Lymphoma Therapeutics Market Share by Type (2014-2019)
Table Central & South America Hodgkin's Lymphoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hodgkin's Lymphoma Therapeutics Market Share by Application (2014-2019)
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Hodgkin's Lymphoma Therapeutics Business (2014-2019) (Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Hodgkin's Lymphoma Therapeutics Business (2014-2019)
Table Bristol Myers Squibb Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Hodgkin's Lymphoma Therapeutics Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Hodgkin's Lymphoma Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Merck Company Details
Table Merck Revenue in Hodgkin's Lymphoma Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Hodgkin's Lymphoma Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Hodgkin's Lymphoma Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Hodgkin's Lymphoma Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Global Hodgkin's Lymphoma Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Hodgkin's Lymphoma Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Hodgkin's Lymphoma Therapeutics Market Size Share by Regions in 2025
Figure United States Hodgkin's Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hodgkin's Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Hodgkin's Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hodgkin's Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hodgkin's Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Hodgkin's Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hodgkin's Lymphoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Hodgkin's Lymphoma Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Hodgkin's Lymphoma Therapeutics Market Size by Product (2019-2025)
Figure Global Hodgkin's Lymphoma Therapeutics Market Size by Product in 2025
Table Global Hodgkin's Lymphoma Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Hodgkin's Lymphoma Therapeutics Market Size by Application (2019-2025)
Figure Global Hodgkin's Lymphoma Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
核形成剤及び清澄剤の世界市場：インサイト・予測 Growth in this market is expected to be driven by the growing demand for rigid packaging for foods & beverages.The Asia-Pacific region is the fastest-growing region in the global nucleating (clarifying) agents market. The global Nucleating and Clarifying Agents market is valued at xx million US$ in …- 世界の塞栓剤市場：専門的調査 Embolic Agent is a material used to block off blood flow through a vessel. The global Embolic Agents market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Embolic Agents volume and value at glob…
- バイオコントロール剤の世界市場：インサイト・予測 Diseases hamper the quality and quantity of plant production. Chemical agents such as herbicides and pesticides have been used effectively since long as suppressors of many varieties of pests. However, pests have developed resistance to pesticides due to their extensive usage. Biocontrol agents, whi…
- つや消し剤の世界市場：インサイト・予測 The Matting Agents is a kind of polyurethane resin with epoxy base.The paints & coatings industry is rapidly expanding, owing to the demand from emerging economies and increasing middle-class population. Global Matting Agents market size will increase to xx Million US$ by 2025, from xx Million US$ i…
- 世界のシリカ系艶消し剤市場：専門的調査 Matting agents help control the gloss of the surface on which they are applied. These agents are fine particles that are dispersed in paint and coating formulations in such a way that they scatter the light falling on the surface in a desired, defined manner. The global Silica based Matting Agents m…